Mark A. Velleca

CIK 1706847 · PRESIDENT & CEO · last filed 2026-01-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$212.7K

Companies

2

Total Filings

45

Lifetime Open-Market Net

-$8.88M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BDTX PRESIDENT & CEO 121,522 $1.75 $212.7K $0 13 2026-01-23
G1 Therapeutics, Inc. (GTHX) Delisted Director 173,286 $7.15 $1.24M -$8.88M 32 2023-08-10

Recent Filings · Page 2 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-09-22 G1 Therapeutics, Inc. (GTHX) Delisted Mixed -$262.2K EDGAR
2022-09-19 BDTX Grant (A) +4,294 $11.3K EDGAR
2022-08-18 G1 Therapeutics, Inc. (GTHX) Delisted Mixed -$979.7K EDGAR
2022-06-17 BDTX Grant (A) +5,542 $11.3K EDGAR
2022-06-13 BDTX Grant (A) $0 EDGAR
2022-03-18 BDTX Grant (A) +2,897 $8.7K EDGAR
2022-02-08 G1 Therapeutics, Inc. (GTHX) Delisted Exer (M) +15,000 $5.8K EDGAR
2021-11-10 G1 Therapeutics, Inc. (GTHX) Delisted Exer (M) +40,000 $15.6K EDGAR
2021-08-11 BDTX Grant (A) $0 EDGAR
2021-07-15 G1 Therapeutics, Inc. (GTHX) Delisted Mixed -$558.6K EDGAR
Showing 1120 of 45
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.